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The gastrointestinal (GI) tract (including the pancreas) and
its blood supply are controlled by nerves and hormonal and
paracrine signaling molecules. The nerves supplying the gut
include the parasympathetic and sympathetic divisions of
the autonomic nervous system and the enteric nervous
system (ENS). The ENS is the division of the autonomic
nervous system that is intrinsic to the GI tract. The GI tract
is also supplied by vagal sensory afferent and spinal
sensory afferent nerves. There are many neurotransmitters
that can be released from the autonomic nerves supplying
the gut; however, data from recent studies indicate that
purines are important neurotransmitters that contribute to
control of GI motility, secretion, blood flow, sensation, and
immune function in the gut. The following supplement
contains five chapters that summarize and analyze recent
data highlighting the importance of purinergic mechanisms
controlling gut function in health and disease.
ATP acting at P2X and P2Y receptors is an important
excitatory neurotransmitter in enteric ganglia. The myen-
teric and submucosal plexuses contain synapses where ATP
has been shown to contribute to synaptic excitation. The
ENS is one of only a few parts of the nervous system where
ATP mediates synaptic responses in functionally identified
nerve pathways [1]. The review provided by Drs. Paul
Bertrand and Jianhua Ren (Chapter 1: “Purinergic receptors
and synaptic transmission in enteric neurons”) presents an
analysis and discussion of recent data supporting a role for
ATP as a synaptic transmitter in the myenteric and
submucosal plexuses. Bertrand and Ren discuss the
contributions of ATP to fast and slow synaptic excitation
in enteric ganglia, and they also review recent evidence
relevant to the molecular identity of the purinergic receptors
mediating synaptic excitation. Finally, the authors speculate
about the possible role of purinergic neurotransmission in
enteric ganglia in motility or secretory disorders in the gut.
Neurotransmission in enteric ganglia controls gastroin-
testinal motility, and purinergic signaling between neurons
and between neurons and smooth muscle is an important
component of the mechanisms controlling propulsive
motility patterns. In the second chapter (“Purinergic
mechanisms in the control of gastrointestinal motility”),
Dr. Joel Bornstein reviews the recent literature supporting a
contribution of purinergic signaling to integrative control of
gut motility. Specifically, Bornstein discusses the role of
purinergic transmission in each component of reflex path-
ways. This includes the role of purinergic signaling in
reflex initiation and sensory transduction, integration of the
sensory signal in enteric ganglia and purineric transmission
to the muscle layers. Purinergic transmission facilitates
coordinated contraction and relaxation of the muscle layers.
Just as purinergic neurotransmission in the myenteric
plexus and to the muscle layers is important for normal
propulsive motility patterns, purinergic neurotransmission
is an important component of secretomotor control. In
addition, ATP and other purines can contribute to secreto-
motor control via paracrine signaling mechanisms from
non-neuronal cells types, including enterochromaffin cells.
In Chapter 3, Dr. Fivos Christofi provides an extensive review
(“Purinergic receptors and gastrointestinal secretomotor func-
tion”) of purinergic mechanisms controlling intestinal secre-
tion, particularly electrogenic chloride secretion.
The splanchnic circulation is a critical vascular bed in
that it receives a large fraction of cardiac output. Therefore,
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blood flow through the splanchnic bed will have an
important impact on blood pressure control and overall
hemodynamics. In addition, control of blood flow through
splanchnic blood vessels is important for gastrointestinal
function and absorption of nutrients postprandially.
Splanchnic blood vessels are controlled largely by the
sympathetic nervous system, and ATP is a co-transmitter
released with norepinephrine from perivascular nerves.
Purines released from non-neuronal cells can also act
locally in the splanchnic circulation to alter vascular tone.
Dr. Antonio Albino-Teixeira (Chapter 4: “Purinergic recep-
tors in the splanchnic circulation”) provides a review and
analysis of the literature related to purinergic mechanisms
controlling vascular tone in the splanchnic circulation.
Albino-Teixeira also discusses purinergic signaling and
pathophysiological changes in splanchnic blood flow.
Finally, Dr. Ivana Novak discusses purinergic contribu-
tions to the control of pancreatic function (Chapter 5:
“Purinergic receptors and pancreatic exocrine and endo-
crine function”). Pancreatic function is controlled partly by
the autonomic nervous system as it is supplied by
sympathetic and parasympathetic nerve fibers. ATP and
other purines may contribute to neurotransmission from
these extrinsic pancreatic nerves. Numerous cell types are
present in the pancreas and each of these cell types has the
potential to use purines as intercellular signaling molecules.
This is important because purines can then modulate the
endocrine and exocrine functions of the pancreas.
Two important aspects of purinergic signaling in the gut
not covered here are related to purines and sensory nerve
function and purines in gut immune-system function and
inflammation. Purinergic signaling mechanisms in the gut
wall lead to nociceptive sensation, and these mechanisms
can be upregulated in animal models of visceral hypersen-
sitivity [2]. There is an extensive literature on purinergic
contributions to pain sensation in the gut and elsewhere,
and there are a number of excellent recent reviews that have
covered this topic in detail [3–7]. Intestinal inflammation is
often part of the pathophysiology of visceral pain and
hypersensitivity [6, 7], but inflammation can also lead to
changes in gastrointestinal motor and secretory function [8,
9, 10]. Purinergic signaling is an important part of the
inflammatory response in the gastrointestinal tract, and this
topic has been reviewed recently [11].
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